Floatz logo

Aspirin

Coronary Artery Disorder

Rajaie Cardiovascular Medical and Research CenterSmall moleculePhase 4 / ApprovedActive
BBB
79/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
68/ 100
Competitive Position
95/ 100

Competitive context

15 Active assets in the Coronary Artery Disorder cohort.

Asset / SponsorPhaseRating
Ezetimibe
Canadian Collaborative Research Network
Phase 4BBB
SIMVASTATIN
University of Washington
Phase 4BBB
Rivaroxaban
Sheffield Teaching Hospitals NHS Foundation Trust
Phase 4BBB
Ranolazine
OBS Pakistan
Phase 4BBB
Itavastatin
Yokohama City University Medical Center
Phase 4BBB

View all 48 →

Same molecule, other indications

Aspirin is also rated in:

myocardial infarctionActive
A
Indicative · Phase 4
83 / 100
View asset →
cardiovascular disorderDormant
BBB
Indicative · Phase 4
78 / 100
View asset →
transient ischemic attackActive
BBB
Indicative · Phase 4
77 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →